Fulgent Genetics (FLGT) Net Income towards Common Stockholders (QoQ) (2015 - 2026)
Fulgent Genetics (FLGT) Net Income towards Common Stockholders (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Fulgent Genetics | 515.57 Mn | 258.54 Mn | 25.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.95% |
| Mar 31, 2026 | -6.01% |
| Dec 31, 2025 | -254.39% |
| Sep 30, 2025 | 65.14% |
| Jun 30, 2025 | -64.41% |
| Mar 31, 2025 | -95.82% |
| Dec 31, 2024 | 59.80% |
| Sep 30, 2024 | -68.17% |
| Jun 30, 2024 | 35.30% |
| Mar 31, 2024 | 89.50% |
| Dec 31, 2023 | -877.71% |
| Sep 30, 2023 | -16.72% |
| Jun 30, 2023 | 26.80% |
| Mar 31, 2023 | 36.29% |
| Dec 31, 2022 | -1,892.70% |
| Sep 30, 2022 | -87.90% |
| Jun 30, 2022 | -92.77% |
| Mar 31, 2022 | 48.13% |
| Dec 31, 2021 | -15.17% |
| Sep 30, 2021 | 61.01% |